<DOC>
	<DOCNO>NCT02485496</DOCNO>
	<brief_summary>The purpose study evaluate clinical technical success well safety feasibility E-tegra Stent Graft System use endovascular treatment infrarenal aortic aneurysm .</brief_summary>
	<brief_title>E-tegra Stent Graft System Treatment Infra-renal Abdominal Aortic Aneurysms</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>Patients must comply indication use Patient must infrarenal aortic aneurysm diameter &gt; 5cm infrarenal aortic aneurysm 4 5cm increase size 0.5cm last 6 month Patient must available appropriate followup time duration study Patient sign informed consent intervention Patients one contraindication indicate instruction use Patients infectious aneurysm Patients inflammatory aneurysm Patients pseudoaneurysm Patients rupture traumatic aneurysm Patients suprarenal , juxtarenal , pararenal aneurysm Patients aortic dissection Patients reverse conical neck define &gt; 3mm distal increase 15mm length Patients congenital degenerative Collagen disease connective tissue disorder Patients thrombocytopenia Patients creatinine &gt; 2.4 mg/dl immediately Intervention Patients hyperthyreosis Patients malignancy need chemotherapy Radiation Patients enrol another clinical study Patients life expectancy le 24 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>